SCHEMBL22321978

SCHEMBL22321978

O=P(Oc1cccc(C(F)(F)F)c1)(Oc1cccc(C(F)(F)F)c1)Oc1cccc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
ACP3 P15309 2/20 0.46
LMNA P02545 1/20 0.46
PPARG P37231 4/20 0.44
PPARA Q07869 1/20 0.44
CES2 O00748 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
MMP2 P08253 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1276973 0.91 KDM4E (0.47) KDM4EACP3LMNAPPARGPPARA
SCHEMBL1276968 0.87 KDM4E (0.49) KDM4EACP3LMNAPPARGPPARA
SCHEMBL22321979 0.85 SRC (0.53) KDM4EACP3LMNAPPARGPPARA
SCHEMBL30438735 0.82 ACP3 (0.49) KDM4EACP3LMNAPPARGPPARA
SCHEMBL10837937 0.82 LMNA (0.48) KDM4EACP3LMNAPPARGPPARA
SCHEMBL20710757 0.82 L3MBTL1 (0.49) KDM4ELMNAPPARGPPARAMAPK1
SCHEMBL13301844 0.81 ALDH1A1 (0.48) KDM4EACP3LMNAPPARGPPARA
SCHEMBL1786941 0.81 SOD1 (0.45) LMNATSHRMAPK1L3MBTL1ALDH1A1
SCHEMBL30438896 0.80 KDM4E (0.47) KDM4EACP3LMNAPPARGPPARA
SCHEMBL22321990 0.77 PPARG (0.52) KDM4EACP3LMNAPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2021-02-23 US disclosed
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES SLC35B2, PPIP5K2, PPA1 KDM4E 2030/4885ACP3 78/4885LMNA 4753/4885
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates SLC35B2, PPIP5K2, PPA1 KDM4E 2030/4885ACP3 78/4885LMNA 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.